Alternative management for gynecological cancer care during the COVID‐2019 pandemic: A Latin American survey

Rodriguez, Juliana; Fletcher, A; Heredia, Fernando Martínez; Fernández, R. Expósito; Salazar, Heidy Ramírez; Sanabria, Daniel; Luna, Javier Burbano; Guerrero, Eduardo; Pierre, Marc‐Edy; Rendón, Gabriel; Rosero, Indira; Trujillo, Lina María; Ribeiro, Reitan; Baiocchi, Glauco; Blanco, Aldo López; Malca, Magaly; Hoegl, Jorge; Garnica, Alfredo Borges; Vega, Jorge Lasso de la; Scasso, Santiago; Laufer, J; Estrada, Erick; Criado, Armando Gutierrez; Nuñez, Guillermo Sidney Herbert; León, David Cantú-de; Medina, Gerardo; Gómez, Luis Pendola; Saadi, José; Noll, Florencia; Sandoval, Danilo Arévalo; Oliveira, Alexandre Ferreira; Pareja, René

doi:10.1002/ijgo.13272

Cited by 12 publications

(10 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 crisis could be a catalyst for integrating telemedicine into healthcare systems, reducing in-person consultations, and minimizing patient and health worker exposure. [8][9][10][11] On the one hand, telemedicine provides access to remote care, minimizing the risk of exposure to infection, allowing adaptations to healthcare delivery, and increasing acceptance and adhesion to care plans by patients. Telemedicine also avoids unnecessary hospital visits that are a potential waste of time and resources, as well as contributing to air pollution.…”

Section: Introductionmentioning

confidence: 99%

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Mancebo

Solé-Sedeño

Membrive

et al. 2020

Int J Gynecol Cancer

View full text Add to dashboard Cite

The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedicine and to adapt protocols in this new era. We hereby propose a strategy for routine surveillance both during and beyond the pandemic.

show abstract

Section: Introductionmentioning

confidence: 99%

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Mancebo

Solé-Sedeño

Membrive

et al. 2020

Int J Gynecol Cancer

View full text Add to dashboard Cite

show abstract

“…There were few clinical guidelines and expert recommendations during the coronavirus disease pandemic in 2020. 2 Nonoperative conservative treatment including pharmacological therapies for hormone-sensitive pathologies should be implemented. 3 Health risk assessment by patient history and coronavirus disease pandemic in 2020 test before elective surgery are pivotal to protect both patients and healthcare providers.…”

Section: Discussionmentioning

confidence: 99%

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020

Yi¹,

Ran²,

Li³

2021

CMAR

View full text Add to dashboard Cite

Objective: To investigate whether patients with epithelial ovarian cancer were affected by delayed chemotherapy during the coronavirus disease pandemic in 2020. Materials and Methods: A delay of more than 21 days in the planned chemotherapy was defined as "delayed chemotherapy." Forty-five patients with epithelial ovarian, fallopian tube, and peritoneal cancer were delayed between January 1 and March 30, 2020 in the First Affiliated Hospital of Chongqing Medical University. Thirty-two cases were enrolled in this study. Neoadjuvant chemotherapy was used in 8 cases; palliative chemotherapy was used in 5 cases; and maintenance chemotherapy was used in 19 cases. Data included age, pathological type, surgical pathological stage, chemotherapy time and CA125 levels were collected. The half-life of CA125 and the decrease in CA125 levels before and after delayed chemotherapy were calculated. Results: No patient got coronavirus disease. Compared with patients of ovarian cancer, fallopian tube epithelial cancer and peritoneal epithelial cancer in the same periods in 2019, the half-life of CA125 in neoadjuvant chemotherapy group and recurrence chemotherapy group were more than 20 days, but there was no significant difference. Only when the delayed chemotherapy took place before CA125 turned negative, accompanied by an interval of more than 60 days, the CA125 half-life and the decreased range of CA125 were totally affected. Conclusion:There was no evidence to support that once chemotherapy was delayed it would influence the decrease of CA125, but whether it would affect the long-term effects such as recurrence and five-year survival rate remains to be further followed up.

show abstract

“…Several publications 14,19,20 providing recommendations on the management of specific cancer types during the pandemic, including the perspective of countries with limited resources, 21 can help cancer surgeons to decide which surgery can be safely postponed.…”

Section: The Need For Surgerymentioning

confidence: 99%

Perioperative Cancer Care in the Context of Limited Resources during the COVID-19 Pandemic: Brazilian Society of Surgical Oncology Recommendations

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background. As the COVID-19 pandemic moves from rich to poor nations, the healthcare systems of developing countries have to deal with this extra burden. As cancer care cannot stop and surgery is the main mechanism for cure and palliation, it is important to provide safe and rational access to cancer surgery during the COVID-19 pandemic. Methods. From April 1st to May 1st, the committee of the Brazilian Society of Surgical Oncology (BSSO) was responsible for reviewing the literature and writing recommendations for perioperative cancer care in the context of limited resources during the pandemic. The recommendations were submitted to the BSSO board of directors. The orientations that were not consensual were removed and the suggestions were added to the text. From May 15 to 30th, the committee revised the recommendations, aligned them with the objectives of the work and standardize the text. Discussion. The rational use of resources to reduce the risk of surgical cancer patients being operated on during the incubation period of a corona virus infection is important in this context. Prevalence of corona virus in the region, the need for surgery, surgical complexity, patient age and comorbidities, and availability of corona virus testing are central aspects in this matter and are discussed. Conclusions. We present a protocol, focused on the patients' outcomes, for safe and rational use of resources to reduce the risk of surgical cancer patients being operated on during the virus incubation period, in the context of areas with limited resources.

show abstract

Alternative management for gynecological cancer care during the COVID‐2019 pandemic: A Latin American survey

Cited by 12 publications

References 27 publications

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020

Perioperative Cancer Care in the Context of Limited Resources during the COVID-19 Pandemic: Brazilian Society of Surgical Oncology Recommendations

Contact Info

Product

Resources

About